MDLN
Medline Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
34.32
▲ 1.74 (5.34%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
32.88
Prev close
32.58
Day high
34.34
Day low
32.51
Volume
6.99M
Market cap
$46.09B
P/E (TTM)
42.82
52W range
32.49 – 50.88
Insider net activity
Net shares
-85.51M
Net selling
Buy transactions
19
64.30M shares
Sell transactions
9
149.82M shares
Net transactions
+28
Buys less sells
Sell : buy shares
2.3 : 1
Mixed
Insider-held shares
2.26M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | GIC PRIVATE LTD Beneficial Owner of more than 10% of a Class of Security |
SELL | 1.60M | $57.28M | Indirect |
| Aug 7, 26 | GIC PRIVATE LTD Beneficial Owner of more than 10% of a Class of Security |
SELL | 590.28K | $21.00M | Indirect |
| Aug 6, 26 | GIC PRIVATE LTD Beneficial Owner of more than 10% of a Class of Security |
SELL | 2.25M | $79.97M | Indirect |
| Aug 6, 26 | MOZART HOLDCO INC Beneficial Owner of more than 10% of a Class of Security |
— | 500.00K | — | Direct |
| Jun 16, 26 | GOLWAS DOUGLAS P. Officer and Beneficial Owner of more than 10% of a Class of Security |
SELL | 100.00K | $3.68M | Direct |
| Jun 16, 26 | GOLWAS DOUGLAS P. Officer and Beneficial Owner of more than 10% of a Class of Security |
— | 100.00K | — | Direct |
| Jun 11, 26 | GALANTI RICHARD ALAN Director |
STOCK | 16.39K | $0 | Direct |
| Jun 11, 26 | BLUEDORN TODD M Director |
STOCK | 15.73K | $0 | Direct |
| Jun 11, 26 | SWEET THOMAS W. CPA Director |
STOCK | 17.80K | $0 | |
| Jun 5, 26 | CORCORAN JESSI L Officer |
BUY | 5.00K | $170.75K | Direct |
| May 28, 26 | HELLMAN & FRIEDMAN CAPITAL PARTNERS X PARALLEL, L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 31.87M | $1.16B | Indirect |
| May 28, 26 | BX MOZART ML-2 HOLDCO L.P. Beneficial Owner of more than 10% of a Class of Security |
SELL | 33.32M | $1.22B | Indirect |
| May 21, 26 | HELLMAN & FRIEDMAN CAPITAL PARTNERS X PARALLEL, L.P Beneficial Owner of more than 10% of a Class of Security |
— | 18.16M | — | Indirect |
| May 21, 26 | BX MOZART ML-1 HOLDCO L.P. Beneficial Owner of more than 10% of a Class of Security |
— | 11.35M | — | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BX MOZART ML-1 HOLDCO L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
BX MOZART ML-2 HOLDCO L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
CARLYLE GROUP, INC. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
GIC PRIVATE LTD |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
HELLMAN & FRIEDMAN CAPITAL PARTNERS X PARALLEL, L.P |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
MILLS ANDREW J. |
Director | — | Purchase |
MILLS CHARLES N. |
Director | — | Purchase |
MOZART AGGREGATOR II LP |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
MOZART HOLDCO INC |
Beneficial Owner of more than 10% of a Class of Security | 787.65K | Conversion of Exercise of derivative security |
TC GROUP VII S1, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
Unusual options activity
Flagged1
Total notional$308.75K
Call notional$308.75K
Put notional$0
Tiltcall-weighted
Likely opening1 of 1
| Side | Strike | Expiry | Volume | Open int. | Vol / OI | Notional | IV | Score | |
|---|---|---|---|---|---|---|---|---|---|
| CALL | 35.00 | Sep 18, 26 26d |
2.38K | 244 | 9.7× | $308.75K | 46% | at bid | 77 |
How this is calculated, and what it cannot see
A contract is flagged when today's volume approaches or exceeds its open interest, the position is worth at least $40,000, and at least 150 contracts changed hands. Open interest is what was outstanding at yesterday's close, so volume above it means the flow cannot all be closing — something is being opened.
The score weights four things: volume against open interest, dollar notional, volume against the rest of that chain, and where the last print sat inside the bid/ask spread.
What it cannot see. Volume here is a daily total, so ten small orders and one large one are indistinguishable — this is not block or sweep detection, which needs exchange-level time and sales. The print column compares the last trade to the current quote, which is a proxy for who was the aggressor, not a tagged flag. Quotes are delayed. A single large trade can be a hedge, a roll, or one leg of a spread, and none of those mean what a naked directional bet would mean.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.24
Call-heavy session
Put / call open interest
1.42
Positioning, not flow
Max pain
35.00
+2.2% from spot
ATM implied vol
45.7%
Nearest strike to spot
Skew (10% OTM)
-1.7%
Calls bid over puts
Call volume
2.65K
Contracts, this expiry
Put volume
635
Contracts, this expiry
Heaviest call OI
37.50
1.33K contracts
Heaviest put OI
30.00
3.43K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-4.14%
-2.8%
1M
-8.96%
-12.7%
3M
-7.65%
-10.8%
6M
-31.20%
-42.3%
YTD
-18.43%
-30.7%
1Y
—
-20.0%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$46.09B
Enterprise value$47.50B
Revenue (TTM)$29.94B
Gross profit$7.85B
EBITDA$2.85B
Net income$701.00M
EPS (TTM)$0.80
Free cash flow$1.06B
Total cash$2.70B
Total debt$12.64B
Book value / share$13.20
Shares outstanding877.35M
Float341.00M
Short % of float8.21%
Dividend yield—
Beta (5Y)—
Short interest
Shares short
34.56M
Prior 36.30M
Change vs prior
-4.8%
Shorts covering
% of float
8.21%
Normal
% of shares out
3.94%
Against total outstanding
Days to cover
5.5
Crowded exit
Float
341.00M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E42.82
Forward P/E21.77
PEG ratio—
Price / sales—
Price / book2.60
EV / revenue1.59
EV / EBITDA16.67
Gross margin26.20%
Operating margin5.14%
Profit margin2.31%
Return on equity4.93%
Return on assets3.01%
Debt / equity66.26
Current ratio4.33
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $28.43B | — | — | — | — |
| Operating revenue | $28.43B | — | — | — | — |
| Cost of revenue | $20.91B | — | — | — | — |
| Gross profit | $7.52B | — | — | — | — |
| Selling, general & admin | $4.52B | — | — | — | — |
| Total operating expense | $5.31B | — | — | — | — |
| Operating income | $2.21B | — | — | — | — |
| Net interest income | -$812.00M | — | — | — | — |
| Pre-tax income | $1.25B | — | — | — | — |
| Tax provision | $91.00M | — | — | — | — |
| Net income | $1.16B | — | — | — | — |
| Net income to common | $1.16B | — | — | — | — |
| Basic EPS | 1.43 | 0.66 | 0.13 | -0.01 | +117.4% |
| Diluted EPS | 1.43 | 0.66 | 0.13 | -0.01 | +117.4% |
| EBIT | $2.06B | — | — | — | — |
| EBITDA | $3.07B | — | — | — | — |
| Basic shares | 812.00M | 1.83B | 1.83B | 1.83B | -55.6% |
| Diluted shares | 812.00M | 1.83B | 1.83B | 1.83B | -55.6% |
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $1.94B | — | — | — |
| Cash & short-term investments | $1.94B | — | — | — |
| Accounts receivable | $3.53B | — | — | — |
| Inventory | $4.77B | — | — | — |
| Total current assets | $10.68B | — | — | — |
| Property, plant & equipment | $4.78B | — | — | — |
| Goodwill & intangibles | $21.97B | — | — | — |
| Total assets | $38.48B | — | — | — |
| Total current liabilities | $2.49B | — | — | — |
| Current debt | $77.00M | — | — | — |
| Long-term debt | $12.48B | — | — | — |
| Total debt | $12.63B | — | — | — |
| Total liabilities | $19.20B | — | — | — |
| Retained earnings | -$7.00M | $0 | — | — |
| Shareholder equity | $10.74B | $16.52B | $55.00M | -35.0% |
| Working capital | $8.19B | — | — | — |
| Net tangible assets | -$11.23B | -$6.10B | -$22.27B | -84.2% |
| Shares issued | 812.00M | 812.00M | 799.80M | 0.0% |
| Line item | 2025 | 2023 | YoY |
|---|---|---|---|
| Net income | $1.16B | — | — |
| Depreciation & amortisation | $1.01B | — | — |
| Stock-based compensation | $76.00M | — | — |
| Change in working capital | -$783.00M | $199.00M | -493.5% |
| Operating cash flow | $1.74B | — | — |
| Capital expenditure | -$447.00M | -$275.00M | -62.5% |
| Investing cash flow | -$474.00M | — | — |
| Share buybacks | -$2.00B | — | — |
| Dividends paid | -$518.00M | — | — |
| Financing cash flow | $399.00M | — | — |
| Free cash flow | $1.30B | $1.41B | -8.0% |
| End cash position | $1.94B | — | — |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $7.68B | $7.35B | $7.79B | — | — | $6.64B | +4.5% |
| Operating revenue | $7.68B | $7.35B | $7.79B | — | — | $6.64B | +4.5% |
| Cost of revenue | $5.47B | $5.51B | $5.87B | — | — | $4.82B | -0.7% |
| Gross profit | $2.21B | $1.84B | $1.91B | — | — | $1.82B | +20.3% |
| Selling, general & admin | $1.29B | $1.23B | $1.26B | — | — | $1.07B | +5.5% |
| Total operating expense | $1.82B | $1.42B | $1.49B | — | — | $1.25B | +28.3% |
| Operating income | $395.00M | $422.00M | $425.00M | — | — | $571.00M | -6.4% |
| Net interest income | -$119.00M | -$136.00M | -$166.00M | — | — | -$210.00M | +12.5% |
| Pre-tax income | $235.00M | $291.00M | $206.00M | — | — | $338.00M | -19.2% |
| Tax provision | $96.00M | $52.00M | $26.00M | — | — | $16.00M | +84.6% |
| Net income | $60.00M | $129.00M | $182.00M | — | — | $322.00M | -53.5% |
| Net income to common | $59.00M | $132.00M | $182.00M | — | — | $322.00M | -55.3% |
| Basic EPS | 0.07 | 0.16 | -0.01 | 0.18 | 0.42 | — | -56.3% |
| Diluted EPS | 0.07 | 0.16 | -0.01 | 0.18 | 0.42 | — | -56.3% |
| EBIT | $403.00M | $456.00M | $372.00M | — | $612.00M | $582.00M | -11.6% |
| EBITDA | $659.00M | $710.00M | $633.00M | — | $862.00M | $829.00M | -7.2% |
| Basic shares | 857.00M | 819.08M | 810.00M | 1.83B | 799.80M | — | +4.6% |
| Diluted shares | 861.00M | 824.84M | 810.00M | 1.83B | 799.80M | — | +4.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.33B | $2.24B | $1.94B | — | — | — | +4.1% |
| Cash & short-term investments | $2.68B | $2.24B | $1.94B | — | — | — | +19.7% |
| Accounts receivable | $3.66B | $3.67B | $3.53B | — | — | — | -0.4% |
| Inventory | $4.67B | $4.81B | $4.77B | — | — | — | -3.0% |
| Total current assets | $11.74B | $11.18B | $10.68B | — | — | — | +5.0% |
| Property, plant & equipment | $4.70B | $4.76B | $4.78B | — | — | — | -1.3% |
| Goodwill & intangibles | $21.61B | $21.79B | $21.97B | — | — | — | -0.8% |
| Total assets | $39.35B | $39.01B | $38.48B | — | — | — | +0.9% |
| Total current liabilities | $2.71B | $2.54B | $2.49B | — | — | — | +6.9% |
| Current debt | $29.00M | $77.00M | $77.00M | — | — | — | -62.3% |
| Long-term debt | $12.55B | $12.49B | $12.48B | — | — | — | +0.4% |
| Total debt | $12.64B | $12.64B | $12.63B | — | — | — | +0.0% |
| Total liabilities | $20.27B | $19.66B | $19.20B | — | — | — | +3.1% |
| Retained earnings | $182.00M | $122.00M | -$7.00M | — | — | $0 | +49.2% |
| Shareholder equity | $11.57B | $11.27B | $10.74B | $127.00M | $128.00M | — | +2.7% |
| Working capital | $9.03B | $8.64B | $8.19B | — | — | — | +4.5% |
| Net tangible assets | -$10.04B | -$10.52B | -$11.23B | -$22.01B | -$22.19B | — | +4.6% |
| Shares issued | 877.00M | 846.00M | 812.00M | 799.80M | 799.80M | — | +3.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $139.00M | $239.00M | $180.00M | $333.00M | $322.00M | -41.8% |
| Depreciation & amortisation | $256.00M | $254.00M | $261.00M | $250.00M | $247.00M | +0.8% |
| Stock-based compensation | $29.00M | $23.00M | $27.00M | $15.00M | $19.00M | +26.1% |
| Change in working capital | -$163.00M | -$161.00M | -$282.00M | -$507.00M | $5.00M | -1.2% |
| Operating cash flow | $715.00M | $412.00M | $229.00M | $197.00M | $682.00M | +73.5% |
| Capital expenditure | -$111.00M | -$96.00M | -$138.00M | -$110.00M | -$98.00M | -15.6% |
| Investing cash flow | -$461.00M | -$96.00M | -$138.00M | -$143.00M | -$92.00M | -380.2% |
| Share buybacks | $0 | $0 | -$1.97B | -$6.00M | -$9.00M | — |
| Dividends paid | — | — | -$96.00M | — | — | — |
| Financing cash flow | -$159.00M | -$13.00M | $897.00M | -$328.00M | -$9.00M | -1,123.1% |
| Free cash flow | $604.00M | $316.00M | $91.00M | $87.00M | $584.00M | +91.1% |
| End cash position | $2.33B | $2.24B | $1.94B | $584.00M | $840.00M | +4.1% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.32 | 0.50 | +55.8% |
| Mar 2026 | 0.29 | 0.33 | +12.2% |
| Dec 2025 | 0.24 | 0.38 | +59.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.35 | 22 | $7.72B | — |
| Next quarter | 0.40 | 22 | $8.47B | +8.8% |
| Current year | 1.52 | 25 | $31.23B | +9.9% |
| Next year | 1.57 | 25 | $33.67B | +7.8% |
Analyst targets & ownership
Mean target$44.62
High target$55.00
Low target$34.00
Implied upside30.00%
Analyst count26
ConsensusBUY
Strong buy / Buy7 / 16
Hold4
Sell / Strong sell0 / 0
Held by insiders0.26%
Held by institutions115.33%
Institutions holding551
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 11, 26 | Tigress Financial | MAINTAINED | Buy | Buy |
| Aug 11, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 10, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Aug 6, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Stifel | MAINTAINED | Buy | Buy |
| Jul 31, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 3, 26 | Baird | MAINTAINED | Outperform | Outperform |
| Jun 1, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| May 14, 26 | BNP Paribas | MAINTAINED | Neutral | Neutral |
Moving averages & technicals
SMA 10
34.54
-0.64% from price
SMA 20
36.65
-6.52% from price
SMA 50
37.99
-9.81% from price
SMA 100
39.60
-13.33% from price
SMA 200
—
—
EMA 12
35.02
-2.00% from price
EMA 26
36.41
-5.74% from price
EMA 50
37.52
-8.54% from price
RSI (14)
41.9
Neutral
MACD (12,26,9)
-1.39
Hist -0.28
ATR (14)
1.97
5.74% of price
Realised vol 30D
60.7%
Annualised
Bollinger upper
42.17
20, 2σ
Bollinger lower
31.13
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Risk profile
Beta vs SPY
0.59
Less volatile than market
Correlation to SPY
0.17
Largely independent
Realised vol 30D
60.7%
Annualised
Market vol 1Y
13.4%
SPY, annualised
Max drawdown 1Y
-34.8%
Peak to trough
Max drawdown 5Y
-34.8%
Peak to trough
ATR 14
1.97
5.74% of price
Beta (reported)
—
5Y monthly, from filing
SEC filings
Periodic Financial Reports
10-Q · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-07-09
Corporate Changes & Voting Matters
8-K · 2026-06-12
Corporate Changes & Voting Matters
8-K · 2026-06-02
Offering Registrations
S-1MEF · 2026-05-21
A correspondence can be sent as a document with another submission type or can be sent as a separate submission
CORRESP · 2026-05-20
Corporate Changes & Voting Matters
8-K · 2026-05-06
Proxy Statements
DEF 14A · 2026-04-23
Headlines
Tigress Financial Adjusts Medline Price Target to $55 From $62, Maintains Buy Rating
MT Newswires · 8d ago
Medline (MDLN) Q2 2026 Earnings Call Transcript
Motley Fool · 10d ago
RBC Capital Adjusts Medline Price Target to $46 From $53, Maintains Outperform Rating
MT Newswires · 16d ago
BofA Securities Adjusts Price Target on Medline to $46 From $53
MT Newswires · 16d ago
Deutsche Bank Adjusts Medline Price Target to $37 From $42, Maintains Hold Rating
MT Newswires · 16d ago
Truist Securities Adjusts Price Target on Medline to $47 From $56, Maintains Buy Rating
MT Newswires · 17d ago
Medline Inc (MDLN) (Q2 2026) Earnings Call Highlights: Strong Growth Amidst Strategic ...
GuruFocus.com · 17d ago
These Two Medical Stocks Are Screaming Sell — Here's What Happened
Investor's Business Daily · 17d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.